Skip to main content
Home

Top menu InfoLep

  • About InfoLep


Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Publications
  • Practical materials
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Ofloxacin - OFLO

Filter by type

  • Publications
  • Content pages

NTD

  • Leprosy (Hansen disease) (76)

Subject

  • Tuberculosis (406)
  • Diagnostic tests (239)
  • Quality of life (236)
  • Contacts / Contact tracing (219)
  • Immunoprophylaxis / Vaccine (216)
  • Reversal reaction (Type 1 reaction) (171)
  • Surgery (127)
  • COVID-19 (127)
  • Diabetes (97)
  • Comorbidity (96)
  • Disability grading (92)
  • Environmental conditions (86)
  • Medical rehabilitation (77)
  • Access to health care (71)
  • Bioarchaeology of leprosy (63)
  • Mycobacterium indicus pranii (MIP) (61)
  • Self-care groups (51)
  • Foot wear (45)
  • Global leprosy situation (38)
  • Clarithromycin - CLARI (38)
  • Terminology as subject (38)
  • Conflict & humanitarian emergencies (27)
  • Nonhuman primates (25)
  • Mass Drug Administration (MDA) (21)
  • Dengue (19)
  • Assistive devices (prostethics and orthotics) (17)
  • Participation in leprosy services (16)
  • Zoonotic NTDs (14)
  • IAL (5)
  • 5-QSI-CS (2)
  • Children (348)
  • Nerve function impairment (NFI) (295)
  • Delays in diagnosis (140)
  • Inclusive development (138)
  • Preventive Chemotherapy (PC) (136)
  • HIV/AIDS (129)
  • (Social) participation (121)
  • Foot-related problems (121)
  • Wound care (107)
  • Dapsone (99)
  • Armadillos (89)
  • Costs / Cost-effectiveness of interventions (64)
  • Epilepsy (50)
  • Leprosy in the middle ages (18)
  • Madrid (12)
  • Postoperative care (8)
  • Occupational Therapy (6)
  • World Leprosy Day (WLD) (6)
  • CATIS Scale (3)
  • Noma (3)
  • School-based approach (3)
  • Decolonisation (2)
  • Erythema nodosum leprosum - enl (Type 2 reaction) (399)
  • Eye-care (262)
  • Social Economic Rehabilitation (197)
  • SDR-PEP (82)
  • Nutrition (80)
  • Hands (64)
  • Migration (40)
  • Economic burden for patients (40)
  • Minocycline - MINO (38)
  • Squirrels (26)
  • WHO classification (20)
  • Taeniasis/cysticercosis (9)
  • Ebola (6)
  • History of ILEP (5)
  • CHIEF (1)
  • Community-based rehabilitation (cbr) (158)
  • Health education (148)
  • Ridley-Jopling Scale (66)
  • Poverty (61)
  • Historical distribution of leprosy (34)
  • Moxifloxacin (20)
  • Hearing loss (5)
  • Clinical Profile (3)
  • Public health (341)
  • Transmission (185)
  • Oral health (44)
  • EMIC Scale (29)
  • ML-Flow test (9)
  • Nitazoxanide - NTZ (1)
  • (-) Ofloxacin - OFLO (77)
  • Nonhuman sources of leprosy (67)
  • Belief (53)
  • Pain management (35)
  • EMIC-CS Community Stigma (19)
  • Case detection (295)
  • Sustainable Development Goals (SDGs) (44)
  • Pregnancy (40)
  • Prednisolone (10)
  • Classification (220)
  • Rifampicin - RMP (115)
  • Capacity building (53)
  • ISMI Scale (8)
  • History of leprosy (471)
  • Rifapentine - RPT (10)
  • Leprosy Internalised Stigma Scale (LISS) (2)
  • Complications and reactions (1077)
  • Multi-drug therapy (MDT) (286)
  • Participation scale (48)
  • Uniform multi-drug therapy (U-MDT) (35)
  • P-scale short (5)
  • Participative rural appraisal (1)
  • PHQ-9 (8)
  • Salsa Scale (44)
  • SARI stigma scale (9)
  • SDS Scale (14)
  • SRQ Self-reporting questionnaire (13)
  • WGQ Washington Group questions (2)
  • WEMWBS (6)
  • WHODAS (11)
  • WHOQOL-BREF (42)
  • Evidence of effectiveness (24)
  • Advocacy (25)
  • Artificial Intelligence & deep learning (11)
  • Social behavior change (13)
  • Social determinants of health (33)
  • Data management and analysis (5)
  • Neglected tropical diseases (NTDs) (985)
  • One Health (15)
  • Skin related NTDs (211)
  • Health & Development (125)
  • Climate change (23)
  • Health systems factors (132)
  • Integrated approach (128)
  • Urban areas / urbanization (17)
  • Accredited social health activists (ASHAs) (13)
  • Vulnerable groups (29)
  • Epidemiology (756)
  • Gender (233)
  • SRHR (15)
  • Prevention of disease (199)
  • Indicators (54)
  • Diagnosis (1013)
  • Management of disease complication (155)
  • Treatment (646)
  • Drug resistance (171)
  • Disability (808)
  • Prevention of disability (pod) (193)
  • Self-care (128)
  • Rehabilitation (107)
  • Mortality (25)
  • Stigma (700)
  • Mental health (358)
  • Stigma (leprosy related) (648)
  • Discriminatory laws & Legislation (43)
  • Human rights (98)
  • WASH (104)
  • Digital health interventions (105)
  • Geographic Information Systems (GIS) & Mapping (157)
  • Mathematical Modeling (9)
  • Tools (184)
  • Leprosy Specific (65)
  • Noncommunicable diseases (NCDs) (17)
  • Communicable Diseases (11)
  • Psoriasis (8)
  • Research skills and ethics (44)

Resource type

  • Article (70)
  • Chapter (1)
  • Dissertation / Thesis (2)
  • Full text online (44)
  • Letter to the editor (3)
  • Systematic review (1)

Journal

  • Acta leprologica (1)
  • American journal of clinical and experimental medicine (1)
  • Anais brasileiros de dermatologia (1)
  • Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] (1)
  • Antimicrobial agents and chemotherapy (6)
  • Arzneimittel-Forschung (1)
  • Bulletin de la Societe de pathologie exotique (1990) (1)
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (1)
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (1)
  • Clinical pharmacology : advances and applications (1)
  • Computational and structural biotechnology journal (1)
  • Current Science (1)
  • European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (1)
  • Indian journal of dermatology, venereology and leprology (1)
  • Indian journal of leprosy (4)
  • Internal medicine (Tokyo, Japan) (1)
  • International journal of antimicrobial agents (1)
  • International journal of dermatology (4)
  • International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association (6)
  • International journal of molecular sciences (1)
  • JAMA (1)
  • Journal of cutaneous medicine and surgery (1)
  • Journal of global antimicrobial resistance (4)
  • Journal of Science and Technology - Awlad Ali (1)
  • Journal of Skin and Sexually Transmitted Diseases (1)
  • Journal of the European Academy of Dermatology and Venereology : JEADV (1)
  • Journal of the Indian Medical Association (1)
  • Journal of the Medical Association of Thailand = Chotmaihet thangphaet (1)
  • Lancet (London, England) (1)
  • Leprosy review (8)
  • Leprosy Review (3)
  • Medecine tropicale : revue du Corps de sante colonial (1)
  • Microbial drug resistance (Larchmont, N.Y.) (1)
  • Mycobacterial Diseases (1)
  • Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association (2)
  • Pharmacotherapy (1)
  • PLOS Neglected Tropical Diseases (1)
  • Revista da Sociedade Brasileira de Medicina Tropical (2)
  • Serbian Journal of Dermatology and Venereology (1)
  • The American journal of tropical medicine and hygiene (1)
  • The Journal of infection (1)
  • The National medical journal of India (1)
  • Tropical Medicine & International Health (1)
  • Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges (1)

Year of Publication

  • 2024 (0)
  • 2023 (9)
  • 2022 (6)
  • 2021 (2)
  • 2020 (5)
  • 2019 (2)
  • 2018 (1)
  • 2017 (3)
  • 2016 (1)
  • 2015 (1)
  • 2014 (0)
  • 2013 (1)
  • 2012 (2)
  • 2011 (2)
  • 2010 (2)
  • 2009 (0)
  • 2008 (2)
  • 2007 (1)
  • 2006 (2)
  • 2005 (2)
  • 2004 (1)
  • 2003 (2)
  • 2002 (1)
  • 2001 (2)
  • 2000 (4)
  • 1999 (1)
  • 1998 (2)
  • 1997 (4)
  • 1996 (4)
  • 1995 (3)
  • 1994 (3)
  • 1993 (0)
  • 1992 (3)
  • 1991 (0)
  • 1990 (0)
  • 1989 (0)
  • 1988 (0)
  • 1987 (1)
  • 1986 (1)
  • 1985 (0)
  • 1984 (0)
  • 1983 (0)
  • 1982 (0)
  • 1981 (0)
  • 1980 (0)
  • 1979 (0)
  • 1978 (0)
  • 1977 (0)
  • 1976 (0)
  • 1975 (0)
  • 1974 (0)
  • 1973 (0)
  • 1972 (0)
  • 1971 (0)
  • 1970 (0)
  • 1969 (0)
  • 1968 (0)
  • 1967 (0)
  • 1966 (0)
  • 1965 (0)
  • 1964 (0)
  • 1963 (0)
  • 1962 (0)
  • 1961 (0)
  • 1960 (0)
  • 1959 (0)
  • 1958 (0)
  • 1957 (0)
  • 1956 (0)
  • 1955 (0)
  • 1954 (0)
  • 1953 (0)
  • 1952 (0)
  • 1951 (0)
  • 1950 (0)
  • 1949 (0)
  • 1948 (0)
  • 1947 (0)
  • 1946 (0)
  • 1945 (0)
  • 1944 (0)
  • 1942 (0)
  • 1941 (0)
  • 1940 (0)
  • 1939 (0)
  • 1938 (0)
  • 1937 (0)
  • 1936 (0)
  • 1935 (0)
  • 1934 (0)
  • 1933 (0)
  • 1932 (0)
  • 1931 (0)
  • 1930 (0)
  • 1929 (0)
  • 1928 (0)
  • 1927 (0)
  • 1926 (0)
  • 1925 (0)
  • 1924 (0)
  • 1923 (0)
  • 1922 (0)
  • 1921 (0)
  • 1920 (0)
  • 1919 (0)
  • 1917 (0)
  • 1916 (0)
  • 1915 (0)
  • 1914 (0)
  • 1913 (0)
  • 1912 (0)
  • 1911 (0)
  • 1910 (0)
  • 1909 (0)
  • 1908 (0)
  • 1907 (0)
  • 1906 (0)
  • 1905 (0)
  • 1904 (0)
  • 1903 (0)
  • 1902 (0)
  • 1901 (0)
  • 1899 (0)
  • 1898 (0)
  • 1897 (0)
  • 1896 (0)
  • 1895 (0)
  • 1893 (0)
  • 1892 (0)
  • 1891 (0)
  • 1890 (0)
  • 1889 (0)
  • 1888 (0)
  • 1886 (0)
  • 1883 (0)
  • 1881 (0)
  • 1880 (0)
  • 1879 (0)
  • 1878 (0)
  • 1877 (0)
  • 1876 (0)
  • 1875 (0)
  • 1874 (0)
  • 1873 (0)
  • 1872 (0)
  • 1870 (0)
  • 1868 (0)
  • 1867 (0)
  • 1866 (0)
  • 1864 (0)
  • 1863 (0)
  • 1861 (0)
  • 1857 (0)
  • 1855 (0)
  • 1847 (0)
  • 1800 (0)
  • 1765 (0)
  • 93 (0)
  • 2 (0)
  • 0 (0)

Language

  • English (57)
  • English (8)
  • French (3)
  • Japanese (2)
  • Portuguese (3)
  • Portuguese (1)
  • Russian (1)

Regional focus

  • African Region (AFR) (1)
    • Benin (1)
    • Burkina Faso (1)
    • Ethiopia (1)
    • Guinea (1)
    • Liberia (1)
    • Madagascar (1)
    • Mali (1)
    • Mozambique (1)
    • Niger (1)
  • European Region (EUR) (2)
    • France (2)
  • Pakistan (1)
  • Region of the Americas (AMR) (7)
    • Brazil (7)
    • Colombia (1)
    • USA (1)
  • South-East Asia Region (SEAR) (9)
    • India (9)
    • Indonesia (2)
    • Myanmar (1)
    • Nepal (2)
  • Western Pacific Region (WPR) (1)
    • China (1)
    • Korea, South – Republic of Korea (1)
    • Philippines (1)
    • Vietnam (1)
  • Yemen (1)
 
  • Relevance
  • Date
77 items

Publication

Assessment of knowledge and awareness about leprosy among medical college students in Tripoli

Amer H, Hariba Z. Journal of Science and Technology - Awlad Ali. 2023;
Download PDF

Publication

High frequency of ofloxacin resistance patterns of M. leprae from India: An indication to revisit second line anti-leprosy treatment regimen.

Chhabra S, Narang T, Sahu S, et al. Journal of global antimicrobial resistance. 2023;
Download PDF

Publication

Use of Multidrug Therapy Regimen for Hansen Disease Patients

Nawaz S. Mycobacterial Diseases. 2023; 13 (5) : 1.
Download PDF

Publication

Do steroids cause drug resistance in leprosy?

Prabha N. Lepra. Leprosy Review. 2023; 94 (3) : 253-254.
Download PDF

Publication

Increscent journey of anti-leprosy drug development.

Gautam S, Sharma D, Singh S, et al. Current Science. 2023; 125 (3) : 253-267.
Download PDF

Publication

Reações adversas aos medicamentos de dois esquemas de tratamento da hanseníase em um Centro de Referência Nacional do Brasil

Celestino I. EDUFU - Editora da Universidade Federal de Uberlandia. 2023;

Publication

Scenarios warranting modified treatment regimens in leprosy: A 5-year retrospective study from a tertiary care center

Hamlet C, Nair PS. Scientific Scholar. Journal of Skin and Sexually Transmitted Diseases. 2023;
Download PDF

Publication

A Current Perspective on Leprosy (Hansen’s Disease)

Borah Slater K. Springer International Publishing. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges. 2023;
Download PDF

Publication

The perennial pursuit for an ideal anti-leprosy treatment

Dogra S, Narang T, Mehta H, et al. Lepra. Leprosy Review. 2023; 94 (1) : 89-92.
Download PDF

Publication

Molecular detection of drug resistance in clinical specimens of leprosy patients from a tertiary care leprosy centre in South India

Muthusamy S, Vilvanathan SA, Dhandapany SP, et al. Lepra. Leprosy Review. 2022; 93 (4) : 370-376.
Download PDF

Publication

A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions.

Muddebihal A, Sardana K, Khurana A, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2022;

Publication

Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.

Li X, Li G, Yang J, et al. International journal of molecular sciences. 2022;
Download PDF

Publication

Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: A threat to effective secondary line treatment for rifampicin resistant leprosy cases.

Ahuja M, Singh I, Lavania M, et al. Journal of global antimicrobial resistance. 2022;
Download PDF

Publication

Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.

Andrade E, Brandão J, da Silva J, et al. Antimicrobial agents and chemotherapy. 2022;

Publication

Single-lesion paucibacillary leprosy: a retrospective study of 75 cases treated with the ROM scheme.

Pennini SN, França J, Rebello P, et al. Anais brasileiros de dermatologia. 2022;
Download PDF

Publication

Interaction of Quinolones Carrying New R1 Group with DNA Gyrase.

Park J, Yamaguchi T, Ouchi Y, et al. Microbial drug resistance (Larchmont, N.Y.). 2021;
Download PDF

Publication

Validação de modelo murino para avaliação da atividade antibacteriana de ofloxacina e clofazimina contra o Mycobacterium leprae

Rocha AF. Instituto Lauro de Souza Lima. 2021;

Publication

HARP: a database of structural impacts of systematic missense mutations in drug targets of Mycobacterium leprae..

Vedithi S, Malhotra S, Skwark M, et al. Computational and structural biotechnology journal. 2020;
Download PDF

Publication

Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India.

Lavania M, Darlong J, Singh I, et al. Journal of global antimicrobial resistance. 2020;
Download PDF

Publication

Ofloxacin-Containing Multidrug Therapy in Ambulatory Leprosy Patients: A Case Series.

Faust L, Klowak M, MacRae C, et al. Journal of cutaneous medicine and surgery. 2020;

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page Next ›
  • Last page Last »

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2023 InfoNTD